Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 18, 2014
Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: influence of time between substrate and inducer administrationGuillaume Baneyx, Neil Parrott, Christophe Meille, et al.
Molecular Pharmaceutics|April 27, 2022
Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug DiscoveryDoha Naga, Neil Parrott, Gerhard F Ecker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 2021
Accelerating Clinical Development of Idasanutlin through a Physiologically Based Pharmacokinetic Modeling Risk Assessment for CYP450 Isoenzyme-Related Drug-Drug InteractionsKenichi Umehara, Yumi Cleary, Stephen Fowler, et al.
The AAPS Journal|October 9, 2020
Construction and Verification of Physiologically Based Pharmacokinetic Models for Four Drugs Majorly Cleared by Glucuronidation: Lorazepam, Oxazepam, Naloxone, and ZidovudineLuca Docci, Kenichi Umehara, Stephan Krähenbühl, et al.
Molecular Pharmaceutics|September 15, 2023
A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic ModelingAndrea Andrews-Morger, Michael Reutlinger, Neil Parrott, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 18, 2023
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainmentChristopher A Darlow, Neil Parrott, Richard W Peck, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 15, 2024
In silico modeling and simulation of organ-on-a-chip systems to support data analysis and a priori experimental designNicoló Milani, Neil Parrott, Aleksandra Galetin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 1, 2014
Applications of a 7-day Caco-2 cell model in drug discovery and developmentYing Peng, Preeti Yadava, Aki T Heikkinen, et al.
Clinical Pharmacology and Therapeutics|July 18, 2024
PBPK Modeling of Entrectinib and Its Active Metabolite to Derive Dose Adjustments in Pediatric Populations Co-Administered with CYP3A4 InhibitorsKenichi Umehara, Neil Parrott, Emilie Schindler, et al.
Neuro-Signals|July 27, 2016
Gut Taste Stimulants Alter Brain Activity in Areas Related to Working Memory: a Pilot StudyAnne Christin Meyer-Gerspach, Claudia Suenderhauf, Lukas Bereiter, et al.
Pageof 14